<SEC-DOCUMENT>0001157523-16-007527.txt : 20161207
<SEC-HEADER>0001157523-16-007527.hdr.sgml : 20161207
<ACCEPTANCE-DATETIME>20161207171300
ACCESSION NUMBER:		0001157523-16-007527
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20161201
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20161207
DATE AS OF CHANGE:		20161207

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			USANA HEALTH SCIENCES INC
		CENTRAL INDEX KEY:			0000896264
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				870500306
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35024
		FILM NUMBER:		162039854

	BUSINESS ADDRESS:	
		STREET 1:		3838 WEST PARKWAY BLVD.
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84120-6336
		BUSINESS PHONE:		8019547100

	MAIL ADDRESS:	
		STREET 1:		3838 WEST PARKWAY BLVD.
		STREET 2:		3838 WEST PARKWAY BLVD.
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84120-6336

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	USANA INC
		DATE OF NAME CHANGE:	19930125
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a51473962.htm
<DESCRIPTION>USANA HEALTH SCIENCES, INC. 8-K
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2016 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 10pt">
    <p style="text-align: center">
      <br>
      <font style="font-size: 14pt; font-family: Times New Roman"><b>UNITED
      STATES</b></font><br><br><font style="font-size: 14pt; font-family: Times New Roman"><b>SECURITIES
      AND EXCHANGE COMMISSION</b></font><br><br><font style="font-size: 12pt; font-family: Times New Roman"><b>WASHINGTON,
      D.C. 20549</b></font><br><font style="font-size: 12pt; font-family: Times New Roman">______________</font><br>
    </p>
    <p style="text-align: center">
      <font style="font-size: 14pt; font-family: Times New Roman"><b>FORM 8-K</b></font><br><font style="font-size: 12pt; font-family: Times New Roman">______________</font><br>
    </p>
    <p style="text-align: center">
      <font style="font-size: 12pt; font-family: Times New Roman"><b>CURRENT
      REPORT</b></font><br><br><font style="font-size: 10pt; font-family: Times New Roman">Pursuant
      to Section 13 or 15(d) of</font><br><br>t<font style="font-size: 10pt; font-family: Times New Roman">he
      Securities Exchange Act of 1934</font><br><br><font style="font-size: 10pt; font-family: Times New Roman">Date
      of Report (Date of Earliest Event Reported):</font><br><font style="font-size: 10pt; font-family: Times New Roman">December
      1, 2016</font><br><br><font style="font-size: 24pt"><b>USANA HEALTH
      SCIENCES, INC.</b></font><br><font style="font-size: 10pt; font-family: Times New Roman">(Exact
      name of registrant as specified in its charter)</font><br><br>Utah<br>(State
      or other jurisdiction of incorporation)<br><br>
    </p>
    <div style="text-align:center">
    <table cellspacing="0" style="margin-bottom: 10.0px; width: 100%; margin-left:auto;margin-right:auto; font-size: 10pt; font-family: Times New Roman">
      <tr>
        <td valign="bottom" style="width: 40%; text-align: center; white-space: nowrap; padding-right: 0.0px; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            0-21116
          </p>
        </td>
        <td style="width: 20%">
          &#160;
        </td>
        <td valign="bottom" style="width: 40%; text-align: center; white-space: nowrap; padding-right: 0.0px; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            87-0500306
          </p>
        </td>
      </tr>
      <tr>
        <td valign="top" style="width: 40%; text-align: center; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (Commission File No.)
          </p>
        </td>
        <td style="width: 20%">

        </td>
        <td valign="top" style="width: 40%; text-align: center; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (IRS Employer Identification
          </p>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="width: 40%; text-align: center; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
        <td style="width: 20%">

        </td>
        <td valign="bottom" style="width: 40%; text-align: center; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Number)
          </p>
        </td>
      </tr>
    </table>
    </div>
    <div style="text-align:center">
    <table cellspacing="0" style="width: 100%; margin-bottom: 10.0px; margin-left:auto;margin-right:auto; font-size: 10pt; font-family: Times New Roman">
      <tr>
        <td valign="bottom" style="text-align: center; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            3838 West Parkway Boulevard<br>Salt Lake City, Utah 84120
          </p>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="text-align: center; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <font style="font-family: Times New Roman; font-size: 10pt">(Address
            of principal executive offices,</font> <font style="font-family: Times New Roman; font-size: 10pt">Zip
            Code)</font>
          </p>
        </td>
      </tr>
      <tr>
        <td>
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="top" style="text-align: center; padding-left: 0.0px">
          <p style="font-size: 10pt; font-family: Times New Roman">
            <font style="font-family: Times New Roman; font-size: 10pt">Registrant&#8217;s
            telephone number, including area code: </font><font style="font-size: 10pt">(801)
            954-7100</font>
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p style="text-align: center">
      <br>

    </p>
    <p>
      <font style="font-family: Times New Roman; font-size: 10pt">Check the
      appropriate box below if the Form 8-K filing is intended to
      simultaneously satisfy the filing obligation of the registrant under any
      of the following provisions:</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Written
      communications pursuant to Rule 425 under the Securities Act (17 CFR
      230.425)</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Soliciting
      material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
      240.14d-2(b))</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
      240.13e-4(c))</font>
    </p>
    <div style="width: 100%; margin-bottom: 10pt; margin-right: 0pt; margin-left: 0pt; text-indent: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
<div style="text-align:left">
    <table cellspacing="0" style="width: 100%; margin-bottom: 10.0px; font-size: 10pt; font-family: Times New Roman">
      <tr>
        <td valign="top" style="width: 10%; text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Item 5.02</b>
          </p>
        </td>
        <td valign="top" style="width: 90%; text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Departure of Directors or Certain Officers; Election of
            Directors; Appointment of Certain Officers; Compensatory
            Arrangements of Certain Officers.</b>
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>
      (b),(c),(e)
    </p>
    <p style="text-indent: 30.0px">
      On December 7, 2016, USANA Health Sciences, Inc. (the &#8220;Company&#8221; or
      &#8220;USANA&#8221;) announced that Jim Brown has been appointed as President and
      Chief Operating Officer of the Company.&#160;&#160;
    </p>
    <p style="text-indent: 30.0px">
      Mr. Brown,48, joined USANA in 2006 as Vice President of Operations.&#160;&#160;In
      July 2011, he was appointed Vice President of Global Operations and
      served in that role until July 2012, when he was appointed Chief
      Production Officer.&#160;&#160;He served in that role until November 2013 when he
      was appointed Chief Operating Officer.&#160;&#160;Prior to joining USANA, Mr.
      Brown was employed at Sonoco as a plant manager where he was responsible
      for safety, quality, finance, production, and maintenance. Mr. Brown
      received a bachelor&#8217;s degree with a double major in computer science and
      math, as well as an M.B.A. degree from Francis Marion University in
      Florence, South Carolina.&#160;&#160;
    </p>
    <p style="text-indent: 30.0px">
      As President and Chief Operating Officer, Mr. Brown will continue to
      receive an annual salary of $411,000, which will be reviewed going
      forward by the Compensation Committee.&#160;&#160;Mr. Brown will also continue to
      be eligible to participate in the Company&#8217;s Executive Bonus Plan, and be
      eligible to receive equity grants under the Company&#8217;s 2015 Equity
      Incentive Award Plan.&#160;&#160;He will also be eligible to participate in the
      Company&#8217;s 401K plan and to receive medical and other benefits coverage,
      both of which are generally available to the Company&#8217;s other employees.
      There is no arrangement or understanding between Mr. Brown and any other
      persons pursuant to which Mr. Brown was selected as President and Chief
      Operating Officer. There are no family relationships between Mr. Brown
      and any director or executive officer of the Company and there are no
      relationships between Mr. Brown and the Company or any of its
      subsidiaries that would require disclosure pursuant to Item 404(a) of
      Regulation S-K of the Securities Exchange Act of 1934, as amended.
    </p>
    <p style="text-indent: 30.0px">
      The Company also announced that, effective immediately, Douglas Braun
      will transition out of the role of Chief Marketing Officer and become a
      strategic adviser to the Chief Executive Officer.&#160;&#160;The Company and Mr.
      Braun are negotiating transition documentation and the Company will file
      an amended Current Report on Form 8-K upon the finalization of this
      documentation.
    </p>
    <p style="text-indent: 30.0px">
      The Company issued a press release on December 7, 2016 announcing these
      events. A copy of the press release is furnished as Exhibit 99.1 hereto
      and is incorporated herein by reference.
    </p>
    <p style="text-indent: 30.0px">

    </p>
<div style="text-align:left">
    <table cellspacing="0" style="width: 100%; margin-bottom: 10.0px; font-size: 10pt; font-family: Times New Roman">
      <tr>
        <td valign="top" style="width: 10%; text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Item 9.01</b>
          </p>
        </td>
        <td valign="top" style="width: 90%; text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Financial Statements and Exhibits.</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 10%">

        </td>
        <td style="width: 90%">
          &#160;
        </td>
      </tr>
      <tr>
        <td style="width: 10%">

        </td>
        <td valign="top" style="width: 90%; text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (d)&#160;&#160;Exhibits
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p style="white-space: nowrap">
      99.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Press release issued by USANA Health Sciences, Inc.
      dated December 7, 2016 (furnished herewith).
    </p>
    <p>

    </p>
    <div style="width: 100%; margin-bottom: 10pt; margin-right: 0pt; margin-left: 0pt; text-indent: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center; font-size: 10pt; font-family: Times New Roman">
          2
        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p style="text-align: center">
      <br>
      <font style="font-family: Times New Roman; font-size: 10pt"><b>SIGNATURES</b></font><br>
    </p>
    <p style="text-align: justify; text-indent: 30.0px">
      Pursuant to the requirements of the Securities Exchange Act of 1934, the
      registrant has duly caused this report to be signed on its behalf by the
      undersigned hereunto duly authorized.
    </p>
    <p style="text-align: left">

    </p>
<div style="text-align:left">
    <table cellspacing="0" style="width: 100%; margin-bottom: 10.0px; font-size: 10pt; font-family: Times New Roman">
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td valign="top" style="width: 40%; text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>USANA HEALTH SCIENCES, INC.</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td valign="top" style="width: 40%; text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td valign="top" style="width: 40%; text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
      </tr>
      <tr>
        <td valign="top" style="width: 5%; text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
        <td valign="top" style="width: 55%; text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
        <td valign="top" style="width: 40%; text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            By:<b> </b>/s/ Paul A. Jones
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td valign="top" style="width: 40%; text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Paul A. Jones, Chief Financial Officer
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td valign="top" style="width: 40%; text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td style="width: 40%">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="top" style="width: 5%; text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Date:
          </p>
        </td>
        <td valign="top" style="width: 55%; text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            December 7, 2016
          </p>
        </td>
        <td style="width: 40%">

        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <p style="text-align: center">
      3
    </p>
  </body>
</html>
<!--<!DOCTYPE html
     PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"
     "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">-->
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a51473962ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2016 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 8pt">
    <p style="text-align: right">
      <b>Exhibit 99.1</b>
    </p>
    <p style="text-align: center">
      <font style="font-size: 12pt; font-family: Times New Roman"><b>USANA
      Appoints New President and CIO</b></font>
    </p>
    <p style="text-align: center">
      <font style="font-size: 12pt; font-family: Times New Roman"><b>Exciting
      New Management Changes Announced</b></font>
    </p>
    <p>
      SALT LAKE CITY--(BUSINESS WIRE)--December 7, 2016--Today, USANA (NYSE:
      USNA) announced that Jim Brown has been appointed president and chief
      operations officer (COO) of the company. With nearly 25 years of
      operations management, Mr. Brown brings a wealth of experience to his
      new role. In his new position, Brown will continue his oversight of
      USANA&#8217;s operations, and expand his leadership to other areas.
    </p>
    <p>
      &#8220;Jim has played a pivotal role in our company&#8217;s growth and innovation
      over the past 10 years,&#8221; said USANA CEO Kevin Guest. &#8220;He has also earned
      the trust of our board of directors, management team, employees, and key
      business partners. And with his extensive experience in global
      operations oversight and administration, I believe he is the right
      leader to ensure our company&#8217;s long-term success.&#8221;
    </p>
    <p>
      &#8220;I am honored by the trust that Kevin and the board have placed in me to
      serve in this position,&#8221; Brown said.&#160;&#8220;This is an exciting time in our
      company&#8217;s history, and I look forward to assuming these additional
      responsibilities to support USANA&#8217;s long-term growth strategy.&#8221;
    </p>
    <p>
      USANA also announced the appointment of Walter Noot as chief information
      officer this week. Noot, who brings with him extensive leadership
      experience in the direct selling industry, will be responsible for
      implementing USANA&#8217;s IT strategy and ensuring that all systems necessary
      to support its operations and objectives are in place.
    </p>
    <p>
      For more information about USANA, go to USANA.com.
    </p>
    <p>
      <b>About USANA</b>
    </p>
    <p>
      Founded in 1992, USANA Health Sciences (NYSE: USNA) is a U.S.-based
      nutritional company that manufactures high-quality supplements, personal
      care and healthy food products in its FDA-Registered Drug
      Establishment&#160;in Salt Lake City.&#160;Learn more about USANA by visiting our
      website <u>http://www.usana.com</u> or the official USANA blog <u>http://whatsupusana.com</u>.
    </p>
    <p style="text-align: center">

    </p>
    <p>
      CONTACT:<br>USANA Health Sciences, Inc.<br>Ashley Collins, 801-954-7629<br>Executive
      Director of PR, Social Media and Communications<br>media(at)us.usana(dot)com
    </p>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
